Navigation Links
Stiefel Laboratories, Inc. Announces Expiration of Hart-Scott-Rodino Waiting Period Relating to its Proposal to Acquire Barrier Therapeutics, Inc.
Date:7/29/2008

A HREF="http://www.stiefel.com" target="_new">http://www.stiefel.com .

About Barrier Therapeutics

Barrier Therapeutics is a pharmaceutical company focused on the development and commercialization of products in the field of dermatology. Barrier Therapeutics currently markets three pharmaceutical products in the United States: Xolegel(R) (ketoconazole, USP) Gel, 2%, for seborrheic dermatitis; Vusion(R) (0.25% miconazole nitrate, 15% zinc oxide, 81.35% white petrolatum) Ointment, for diaper dermatitis complicated by documented candidiasis; and Solage(R) (mequinol 2.0%, tretinoin 0.01%) Topical Solution, for solar lentigines. Barrier Therapeutics has other product candidates in various stages of clinical development for the treatment of a range of dermatological conditions, including onychomycosis, psoriasis, acne, skin allergies, and acute fungal infections. The company is headquartered in Princeton, New Jersey and has a wholly-owned subsidiary in Geel, Belgium. More information about Barrier Therapeutics can be found on its corporate website at: http://www.barriertherapeutics.com .

Xolegel, Vusion and Solage are trademarks of Barrier Therapeutics.

Important Information About the Tender Offer

This announcement and the description contained herein are for informational purposes only and are not an offer to purchase or a solicitation of an offer to sell securities of Barrier Therapeutics. Stiefel Laboratories and Bengal Acquisition Inc. have filed with the SEC a tender offer statement on Schedule TO containing an offer to purchase, forms of letters of transmittal and other documents relating to the offer, and Barrier Therapeutics has filed with the SEC a solicitation/recommendation statement on Schedule 14D-9, with respect to the offer. These documents contain important information about the tender offer and the proposed merger. Stockholders of Barrier Therapeutics are
'/>"/>

SOURCE Stiefel Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Stiefel Laboratories, Inc. Acquires ABR Invent and ABR Development
2. Stiefel Laboratories Appoints First Chief Scientific Officer
3. Stiefel Laboratories, Inc. Appoints New President
4. Roxane Laboratories, Inc. Initiates a Nationwide Voluntary Recall of Two Manufacturing Lots of Sodium Polystyrene Sulfonate Suspension in the US and Puerto Rico
5. Roxane Laboratories, Inc. Announces the Approval of Morphine Sulfate Tablets and Oral Solution
6. Mesa Laboratories, Inc. Named to Fortune Small Business Magazines 2008 List
7. Mesa Laboratories, Inc. Added to the Russell Microcap Index
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Elavil(R)
9. Roxane Laboratories, Inc. Announces the Launch of Ramipril Capsules
10. Caraco Pharmaceutical Laboratories, Ltd. Reports Record Results for the Fourth Quarter and Fiscal Year 2008
11. Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... On March 26, 2015, Vogue Magazine UK, in an ... a look into the trend of young women undergoing ... . The article suggests that celebrity endorsements (Beyoncé is cited ... Kardashian and Kylie Jenner are the drivers behind this trend. ... influences on the self-esteem of teenagers. (see: goo.gl/NmaB4q) , “I ...
(Date:3/31/2015)... 2015 Dr. Andrew Lian-Jie ... American Board of Dermatology and fellowship trained Mohs ... at the National Cancer Institute of the National ... in internal medicine at the Emory University and ... Philadelphia. Dr. Li pursued further training in Mohs ...
(Date:3/31/2015)... At Summit Breast Care, their passion is to provide ... caring manner. , Summit Breast Care has achieved national recognition ... cancer. They treat thousands of patients annually, not just ... Their doctors continue to be recognized as ‘Top Doctors’ ... Breast Care were planted in the mind and spirit of ...
(Date:3/31/2015)... 31, 2015 Researchers at UC ... and humans: how human livers heal. The difference ... liver regeneration. Normally, mouse PPARa is far more ... mice to quickly regenerate damaged livers. However, the ... (FGF21) can boost the regenerative effects of human ...
(Date:3/31/2015)... Former 49ers linebacker Chris Borland turned more heads with his ... promising NFL career. In a March episode of SCI ... explores the curious case of Borland and the potential ... process that Borland and other football players will likely use ... and what impact, if any, he thinks this case will ...
Breaking Medicine News(10 mins):Health News:Cosmetic Surgery: Does Social Media Pressure Young Girls to Get Botox and Fillers? 2Health News:Dr. Andrew Li of Warren Skin Care Center Is Celebrating 3 Years Recognized as an "NJ Top Doc" 2Health News:Summit Breast Care is Celebrating Four Years as "NJ Top Docs" 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 2Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 3Health News:UC Davis Study Finds Protein May Improve Liver Regeneration 4Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3
... The anti-AIDS drug market is currently dominated by ... country's largest pharmaceutical company, is planning to enter ... director for India and west Asia, S D ... launch Lamivudine, Nevirapine, Aabacavir and Indinavir products in ...
... Complication as its other name. Among the many complications that ... ulcer, as damage can be severe enough to require amputation. ... in disguise would be a new device that delivers a ... stimulation would help in the healing of foot ulcers. ...
... procedure widely used on knees can also repair damaged ... best known for repairing knee injuries, but it is ... it is a minimally invasive surgical technique it is ... relieve different ankle problems, including ligament damage, bone chips ...
... techniques are being developed on a daily basis. One of ... those suffering from a degenerative eye condition. This degenerative condition ... fluid, causing scarring and loss of vision. ,Eye specialists ... Therapy, which has a lower risk rate of damaging the ...
... Paracetamol, whose active ingredient is Acetaminophen is found effective ... lowers body temperature in people who have had a ... Netherlands. ,Rise in the body temperature during the ... manifest as fever, has been linked to poorer outcomes ...
... pot of gold by making cheap anti-AIDS drugs. This ... escalate in coming days. ,The large number of ... drugs and market it in India and abroad by ... market, currently dominated by Mumbai-based Cipla, witnessed the entry ...
Cached Medicine News:Health News:Arthroscopy for Ankles 2
(Date:3/31/2015)... TAMPA, Fla. , March 31, 2015  Oxis ... biotech cancer therapy development and commercialization, announced today Oxis ... of the trading of Oxis common shares on the ... the OTCQB under the symbol OXIS.   ... "As Oxis continues to move forward with its strategies ...
(Date:3/31/2015)... MIAMI , March 31, 2015 ... TALOS™, today announced a strategic partnership with ... solutions for clinical research in life sciences. Offering ... global CRO has deployed Medidata,s electronic data capture ... support Biorasi,s Phase I through IV global clinical ...
(Date:3/31/2015)... , March 31, 2015  Ajinomoto Althea, Inc. ... development and manufacturing services, announced today that ... companies to its growing list of partners ... products using Althea,s Crystalomics ® ... total of 4 out of 10 of ...
Breaking Medicine Technology:Oxis International Inc. Announces Request for Euronext Trading Suspension 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4Althea's New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies 2
... , ENGLEWOOD, Colo., Dec. 7 ... DoseEdge(TM), during this week,s ASHP Midyear Clinical Meeting (MCM). ... safety and pharmacy efficiency through the management of IV ... into current pharmacy practice and techniques, while providing a ...
... , CARLSBAD, Calif., Dec. 7 Genoptix, Inc. (Nasdaq: ... the Company,s participation at the Deutsche Bank 2009 MedTools Investor ... Mass. on December 9-10, 2009. , Genoptix,s EVP ... the Company on Wednesday, December 9, 2009. He will ...
Cached Medicine Technology:Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3Genoptix Announces Participation at Deutsche Bank 2009 MedTools Investor Conference 2
Fortitude as a unique complement to the spinal concepts family of products....
Caspar cervical retractor (lamina spreader), counter-retractor complete with 5 blades and forceps. Height: max. 165 mm, Maximal spread: 85 mm...
Cervical retractor with double finger hold, 3 depth 75 mm. Smooth...
Scoville cervical disc retractor, self-retaining with ratchet action....
Medicine Products: